- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PharmaBlock Sciences Nanjing Inc (300725)
PharmaBlock Sciences Nanjing Inc stock price live, this page displays SZ 300725 stock exchange data. View the 300725 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PharmaBlock Sciences Nanjing Inc real time stock price chart below.
What Is the PharmaBlock Sciences Nanjing Inc Stock Price Today?
The PharmaBlock Sciences Nanjing Inc stock price today is 45,46.
What Is the Stock Symbol for PharmaBlock Sciences Nanjing Inc?
The stock symbol for PharmaBlock Sciences Nanjing Inc is "300725."
What Stock Exchange Does PharmaBlock Sciences Nanjing Inc Trade On?
PharmaBlock Sciences Nanjing Inc is listed and trades on the Shenzhen stock exchange.
Is PharmaBlock Sciences Nanjing Inc a Good Stock to Buy?
Determining whether PharmaBlock Sciences Nanjing Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300725 quote. (ISIN: CNE1000035K5)
What Is the PharmaBlock Sciences Nanjing Inc Stock Price Today?
The PharmaBlock Sciences Nanjing Inc stock price today is 45,46.
What Is the Stock Symbol for PharmaBlock Sciences Nanjing Inc?
The stock symbol for PharmaBlock Sciences Nanjing Inc is "300725."
What Stock Exchange Does PharmaBlock Sciences Nanjing Inc Trade On?
PharmaBlock Sciences Nanjing Inc is listed and trades on the Shenzhen stock exchange.
Is PharmaBlock Sciences Nanjing Inc a Good Stock to Buy?
Determining whether PharmaBlock Sciences Nanjing Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300725 quote. (ISIN: CNE1000035K5)
Shenzhen
Currency in CNY
45.46
+1.48(+3.37%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.71
46.13
52 wk Range
30.90
57.55
Earnings results expected in 10 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.7146.13
52 wk Range
30.9057.55
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300725 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.00
Earnings
Latest Release
Aug 11, 2026
EPS / Forecast
0,22 / --
Revenue / Forecast
551M / --
Compare 300725 to Peers and Sector
Metrics to compare | 300725 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300725PeersSector | |
|---|---|---|---|---|
P/E Ratio | 50.3x | 38.8x | −0.3x | |
PEG Ratio | −28.52 | 0.93 | 0.00 | |
Price/Book | 2.3x | 2.7x | 2.6x | |
Price / LTM Sales | 5.0x | 5.2x | 2.9x | |
Upside (Analyst Target) | - | 29.0% | 62.0% | |
Fair Value Upside | Unlock | 17.6% | 9.5% | Unlock |
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small molecule drug substance CDMO services, including optimal route scouting; FFS and FTE for process research and development of RSMs, intermediates, and APIs; impurity studies and synthesis; solid state chemistry; analytical development and quality control; cGMP manufacturing of intermediates and APIs; and CMC regulatory filing support. In addition, it offers small molecule DP CDMO services, such as candidate screening and selection, early development, full development, registration, and post-approval; and new modality services, including target protein degrader, peptide, oligonucleotide, and ADC services. PharmaBlock Sciences (Nanjing), Inc. was founded in 2006 and is based in Nanjing, the People's Republic of China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the NJ PharmaBlock (300725) Stock Price Today?
The NJ PharmaBlock stock price today is 45,46 CNY.
What Stock Exchange Does NJ PharmaBlock Trade On?
NJ PharmaBlock is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for NJ PharmaBlock?
The stock symbol for NJ PharmaBlock is "300725."
Does NJ PharmaBlock Pay Dividends? What’s The Current Dividend Yield?
The NJ PharmaBlock dividend yield is 0,9%%.
What Is the NJ PharmaBlock Market Cap?
As of today, NJ PharmaBlock market cap is 10,25B CNY.
What Is NJ PharmaBlock's Earnings Per Share (TTM)?
The NJ PharmaBlock EPS (TTM) is 0,94.
When Is the Next NJ PharmaBlock Earnings Date?
NJ PharmaBlock will release its next earnings report on Oct 30, 2026.
From a Technical Analysis Perspective, Is 300725 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has NJ PharmaBlock Stock Split?
NJ PharmaBlock has split 3 times.
How Many Employees Does NJ PharmaBlock Have?
NJ PharmaBlock has 2593 employees.
What is the current trading status of NJ PharmaBlock (300725)?
As of Oct 20, 2026, NJ PharmaBlock (300725) is trading at a price of 45,46 CNY, with a previous close of 45,46 CNY. The stock has fluctuated within a day range of 42,71 CNY to 46,13 CNY, while its 52-week range spans from 30,90 CNY to 57,55 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.